Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-10-09
2000-07-04
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514739, A61K 3135, A61K 31045
Patent
active
060839791
ABSTRACT:
Method of blocking aberrant Ras signaling in a mammal while avoiding excessive cell toxicity by administration of lovastatin and geranylgeraniol.
REFERENCES:
McGuire et al, J. Biol. Chem. (1996), 271(44), 27402-27407 Abstract Only.
Crick et al., SAAS Bull. Biochem. Biotechnol (1996), 9, 37-42 Abstract Only .
McGuire Terence F.
Sebti Said M.
Goldberg Jerome D.
University of Pittsburgh
LandOfFree
Geranylgeraniol/lovastatin: a novel approach to blocking cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Geranylgeraniol/lovastatin: a novel approach to blocking cancer , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Geranylgeraniol/lovastatin: a novel approach to blocking cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1486971